Plain-English translation of NCT06307938 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →This research study, called CoLiQ, is testing whether doctors can find signs of colorectal cancer in your blood before or during your colonoscopy. The study looks for tiny pieces of cancer DNA that may be floating in the bloodstream — a test called a liquid biopsy. If successful, this blood test could one day help catch colorectal cancer earlier and help doctors personalize your treatment.
Currently, colonoscopy is the main way doctors screen for and diagnose colorectal cancer, but it's invasive and uncomfortable. A simple blood test that could detect cancer before or alongside colonoscopy might help catch the disease earlier and give doctors better information about how to treat each patient's specific cancer.
You likely qualify if…
You likely don't qualify if…
When you come in for your colonoscopy, you'll fill out a short questionnaire about your health and give one blood sample. If you are diagnosed with colorectal cancer during the study, you'll be asked to provide extra blood samples during your regular treatment visits and follow-up appointments. The study involves researchers tracking how the cancer DNA in your blood changes over time to better understand your specific cancer.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Norway
Sponsor
Helse Nord-Trøndelag HF
Collaborators
Norwegian University of Science and Technology
Enrollment target
~3,000 participants
Started
March 2025
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Eivor A Laugsand, MD, PhD
Helse Nord-Trøndelag HF
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.